Biotech grants in the Netherlands

Funds one project to standardise beta-cell manufacturing, immune-tolerance strategies and clinical criteria that speed up cell therapy for type 1 diabetes.

Closed

Funds one consortium to run a microbiome research one-stop-shop and coordination hub for EU policymakers and regulators.

Closed

Funds R&D that turns existing food-safety science — molecular methods, genomics, photonics — into deployable tools against food fraud and safety risks.

Closed

Funds development of lab-grown human tissue models, organ-on-chip systems and AI-driven simulations that can replace animal testing in drug and medical device development.

Funds late-stage development of new diagnostic tests for vector-borne diseases such as those spread by mosquitoes and ticks.

Closed

Funds companies and researchers scaling up precision-fermentation microorganisms that turn captured CO2 into food nutrients.

Closed

Funds AU-EU research consortia developing locally-produced therapeutic and supplementary foods for child malnutrition in Africa.

Closed

Funds industry-academia consortia that refine and scale up the manufacturing process for one class of cell or gene therapy, from quality control through to deployment.

Closed

Funds research into the prevention, diagnosis and treatment of long-term health conditions that persist after a viral, bacterial, parasitic or fungal infection has cleared.

Closed

Pays one consortium to run a public-education and communication campaign on biotech-derived alternative proteins such as precision-fermentation foods.

Closed

Funds bio-based and nature-based reconstruction solutions for areas damaged by conflicts such as the wars in Ukraine and Gaza.

Closed

Funds transnational access to research infrastructure services in one of three areas — industrial biotechnology, radionuclide facilities, or climate prediction.

Funds retrofitting an existing industrial or biorefinery plant to produce higher-value bio-based chemicals or materials than its old process line.

Funds scale-up of protein extraction or production processes from alternative sources like plants, fungi, microorganisms or fermentation, aimed at food use.

Closed

Pays 75% (up to €75K) for satellite-based sustainable-pharma services.

Closed

Funds teams in Germany through a continuous hormone-monitoring challenge for advanced sensor development.

Funds scale-up of safe-and-sustainable bio-based polymers or co-polymers that match or beat fossil-based alternatives on performance.

Funds demonstration of safe-and-sustainable bio-based chemicals or processes that replace hazardous coatings, dyes and solvents used in making textiles.

Closed

Pays one consortium to run an EU-wide bioeconomy networking platform connecting researchers, investors, policymakers and businesses.

Closed

Funds projects that build shared taxonomy databases or a European biodiversity genomics network to speed up species identification.

Closed

Pays one consortium to align bioeconomy research funding and priorities across Central-Eastern Europe, Ukraine, Moldova and the Western Balkans.

Closed

Funds R&D into bio-based alternatives that replace hazardous chemicals like PFAS in industrial products and processes.

Funds companies scaling up sustainable macroalgae cultivation and turning the harvest into new bio-based food, feed or industrial products.

Funds late-stage clinical trials of treatments and diagnostics for six climate-linked diarrhoeal disease pathogens in sub-Saharan Africa.